|
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Top US-accredited Lab Confirms Path-Away(R) Natural Active Ingredient Kills the COVID-19 Virus within Two Minutes
Sydney, Kuala Lumpur, Bluffton, SC, Oct 21, 2020 - (ACN Newswire) - A leading US lab has released results confirming Path-Away®, a plant-based active ingredient that contains no chemicals or alcohol, can kill the virus that causes COVID-19 within two minutes. Path-Away's Anti Pathogenic Aerosol Solution was tested on SARS-CoV-2 by Microbac Laboratories, Inc., accredited by the U.S. Dept of Defence (DoD) and the Environmental Laboratory Accreditation Program (ELAP).
The Microbac tests were conducted using the direct inoculation method, and follow successful tests in an approved UK laboratory (April 2020) on the efficacy of Path-Away® against the feline coronavirus, a recognised surrogate of SARS-CoV-2. Path-Away® has also proven effective against a broad spectrum of microbes including SARS and H1N1 viruses.
Holista Colltech Ltd (ASX: HCT; Holista), the Asian-based distributor, and Global Infection Control Consultants, LLC (GICC LLC), the US-based developer, said the tests confirm Path-Away® as the world's first natural and safe organic disinfectant meeting U.S. testing standards. Holista distributes Path-Away® under its own NatShield™ and Protectene™ brands. Holista and GICC LLC are also co-developing NatShield™ nasal balm with Path-Away®, to launch before the end of 2020.
Holista also has rights to Path-Away® for use in aerosolised disinfection of buildings using a high-pressure fogger. The latest test results will significanly accelerate efforts to roll out the M3 System®, also developed by GICC LLC, which can disinfect large buildings by dispensing Path-Away® through heating, ventilation and air-conditioning (HVAC) systems to treat harmful pathogens, including airborne viruses.
GICC LLC recently secured a 36-month contract with the U.S. Govt to manufacture and install 10 million units of its M3 System® in large buildings. The system measures, monitors and contains airborne (aerosol) viruses, pathogens and other biological contaminants. Holista and GICC will form a 51:49 JV to manufacture the M3 System® in Singapore. Holista is exclusivel distributor of the M3 outside the US, China and Gulf States.
Dr Arthur V Martin, the president of GICC LLC, commented: "This is the first time an organic compound has been proven to kill the virus causing COVID-19, to 99.9% within two minutes. This will speed up the formal U.S. Government process of listing on the Environmental Protection Agency's (EPA) 'List N'. EPA expects products on List N to kill SARS-CoV-2 within two minutes. This will also allow for a wider use of this all-natural disinfectant for human use. The findings by Microbac also confirmed the effects of Path-Away® on other coronaviruses, which follows research showing COVID-19 survives on surfaces longer than scientists had originally calculated."
Dr. Roscoe Moore Jr., D.V.M., Ph.D., D.Sc., Former Assistant U.S. Surgeon and member of the Global Virus Network and its International COVID-19 Taskforce, said "There is a big need for natural and human friendly disinfectants that can be used frequently and safely without long term health side effects and while being environmentally safe. The recent tests from Microbac are most welcome as the public is looking for an agent that acts specifically against COVID-19". Dr Moore also chairs Holista's Scientific Advisory Board.
Dr Rajen Manicka, Chief Executive Officer of Holista, commented: "This product will address the significant untapped global market for all-natural disinfectants that are safe to be used on hands and faces. The results from Microbac will give our customers a greater level of confidence that NatShield™ and Protectene™ can be effective on skin, surfaces and as an aerosol, against the highly contagious COVID-19 causing virus.
"We have also fielded enquiries from large organisations to disinfect buildings and facilities with sizeable human traffic. We are preparing a submission to the Australian Therapeutic Goods Administration (TGA) for approval to label Natshield™ and Protectene™ as sanitizing and disinfectant products, as well as to have Natshield approved for aerosol delivery through fogging units and through HVAC systems in Australia."
Information on Path-Away® and Microbac Test Results
How Path-Away® Works: Path-Away® attaches itself to the virus and inhibits its ability to take up amino acids - their basic building block. This forces the viruses to clump together, in the process killing themselves, almost instantly. The compound is environmentally safe with very low toxicity and does not harm humans and pets.
Test Results by Microbac: - Cells containing the SARS-CoV-2 virus were seeded in 24-well plates and 2.0 mL (millilitres) of Path-Away® was added to the (live frozen samples - thawed out) dried virus inoculum and held for the contact time of 2 minutes at 21 degrees C with 53% relative humidity (RH). For the test to be deemed successful, Path-Away® must demonstrate a ≥ 3 Log10 reduction on each test carrier in the presence or absence of cytotoxicity. - Path-Away® achieved this benchmark in each of the 24 instances (100% success rate). All controls met the criteria for a valid test and Microbac's conclusions are based on observed data. - Log Reduction stands for a 10-fold (one decimal) or 90% reduction in numbers of live bacteria. A 3-Log Reduction equates to a 99.9% reduction - greater than 1,000 time reduction in potentially harmful microorganisms. - Path-Away®, killed 99.9% (≥ 3 Log10) of the COVID-19 causing virus on a hard surface after being exposed to Path-Away®. - The full test report and process will be featured on Holista's website at https://www.holistaco.com/
About Holista Colltech Limited Holista Colltech Ltd (Holista) is a natural wellness company with Dietary supplements, Food Ingredients, Ovine collagen, and Infection Control Solutions. Holista has a global collaboration with Global Infection Control Consultants LLC to use Path-Away®, a plant-based solution that is proven to kill a broad spectrum of microbes, and the all-natural alcohol-free active ingredient used in Holista's range of disinfectant products under the NatShield™ brand.
For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com
Source: Holista CollTech Ltd Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals Dec 15, 2025 23:00 JST
|  NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport Dec 15, 2025 19:41 JST
|  NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz Dec 15, 2025 19:04 JST
|  Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership Dec 15, 2025 08:30 JST
|  HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion Dec 12, 2025 23:15 JST
|  Honda to Launch New Heritage Service Business
Dec 12, 2025 20:31 JST
|  Bank Mandiri Enhances Digital Resiliency for Financial Trading in Indonesia through Advanced Time Sync Solutions with NEC and Adtran Oscilloquartz Dec 12, 2025 19:59 JST
|  NEC and ClimateAi sign a Memorandum of Understanding (MoU) for business co-creation to enhance climate resilience across various industries Dec 12, 2025 18:13 JST
|  Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition Dec 12, 2025 11:00 JST
|  Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year Dec 11, 2025 19:41 JST
|  NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year Dec 11, 2025 19:00 JST
|  MHI Successfully Produces Hydrogen at Its Ammonia Cracking Pilot Plant Using Steam Heating Dec 10, 2025 18:14 JST
|  NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025 Dec 10, 2025 12:00 JST
|  "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List Dec 09, 2025 18:51 JST
|  NEC Wins TIP MUST Silver Badge with Advanced Network Operating System for Open Optical Transponders Dec 09, 2025 13:39 JST
|  MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works Dec 08, 2025 17:00 JST
|  Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes Dec 08, 2025 16:34 JST
|  MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary Dec 08, 2025 16:03 JST
|  Lexus World Premieres Lexus LFA Concept BEV Sports Car Dec 05, 2025 19:13 JST
|  TOYOTA GAZOO Racing World Premieres GR GT & GR GT3 Dec 05, 2025 18:58 JST
|
More Latest Release >>
|